Biotech Archives - Page 7 of 733

1 minute read

Quantum-Si Presents The Use Of Next-Generation Protein Sequencing To Detect Disease-Relevant Proteoforms At The Festival Of Genomics And Biodata

June 10, 9:10 AM

Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced a presentation by Gloria Sheynkman, Ph.D., Assistant Professor in the Department of

QSI

1 minute read

Actinium Highlights Mutation Data From The Phase 3 SIERRA Trial Of Iomab-B And Novel Linker Technology To Support Solid Tumor Antibody Radiation Conjugate Development At The 2024 SNMMI Annual Meeting

By Benzinga Newsdesk

June 10, 8:37 AM

Iomab-B led bone marrow transplant improved survival in patients with high-risk relapsed or refractory acute myeloid leukemia including those with a TP53 mutationIomab-B safely delivered radiation to the target bone

ATNM

1 minute read

NRx Pharmaceuticals Publishes Shareholder Update Letter; Update Highlights Potential Implications Of The Company’s Recent Activities At The Annual Meeting Of The American Society Of Clinical Psychopharmacology

By Benzinga Newsdesk

June 10, 8:34 AM

The June 2024 meeting of the American Society for Clinical Psychopharmacology (ASCP) focused heavily on increasing use of intravenous ketamine and intranasal S-ketamine as the emerging standard of care for treating

NRXP

1 minute read

Monopar To Present Data Showcasing The Appeal Of uPAR As A Radiopharma Cancer Target And Of Its Lead Clinical Program At The 2024 SNMMI Annual Meeting

By Benzinga Newsdesk

June 10, 8:06 AM

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, is presenting today data from the preclinical development of its

MNPR

1 minute read

Lipocine To Present 52 Week Results From LPCN 1148 Phase 2 Study In Late Breaking Session At EASL Congress 2024

By Benzinga Newsdesk

June 10, 8:02 AM

Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking oral presentation at the European Association for the Study

LPCN

1 minute read

EXCLUSIVE: ImmunoPrecise Antibodies’ Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery

By Vandana Singh

June 10, 7:01 AM

ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.

IPA

2 minute read

Arcturus’ Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst

By Vandana Singh

June 7, 2:44 PM

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .

ARCT

2 minute read

Class Action Against Abbott’s Glucerna Products Proceeds in Federal Court

By Vandana Singh

June 7, 2:17 PM

WuXi AppTec employees collaborated with China's PLA on altitude sickness drugs, raising national security concerns in the U.S. Congressional committee calls for restricting biotech ties amid ongoing scrutiny.

ABT

2 minute read

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season

By Vandana Singh

June 7, 12:05 PM

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

BNTX

1 minute read

Vertex To Present New Data Demonstrating Significant Benefits Of Treatment With TRIKAFTA At The ECFS 47th European Cystic Fibrosis Conference Held June 5-8, 2024

By Benzinga Newsdesk

June 7, 12:03 PM

- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations showed statistically significant and clinically meaningful improvements in the

VRTX